Related Experiment Video
Updated: Jun 12, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Coronary artery disease: revascularization strategies for patients with CAD and diabetes
G Robert Myers1, William S Weintraub
1Section of Cardiology, Room 2E99, Christiana Hospital, 4755 Ogletown-Stanton Road, Newark, DE 19718, USA.
Insights
Coronary artery bypass grafting (CABG) may not be the best revascularization for diabetic patients with complex coronary artery disease. New analysis suggests alternative strategies should be considered.
Area of Science:
- Cardiology
- Vascular Surgery
- Interventional Cardiology
Background:
- Coronary artery bypass grafting (CABG) has traditionally been the preferred revascularization strategy for patients with diabetes mellitus and left main or multivessel coronary artery disease.
- The SYNTAX trial provides a robust dataset for evaluating different revascularization approaches in complex coronary artery disease.
Discussion:
- This analysis challenges the long-held belief that CABG is universally optimal for diabetic patients with complex coronary artery disease.
- It prompts a re-evaluation of treatment guidelines and clinical decision-making for this patient population.
Key Insights:
- The study suggests that alternative revascularization strategies beyond CABG may offer comparable or superior outcomes for diabetic patients with left main and/or multivessel coronary artery disease.
- Physicians and patients should be aware of and discuss these additional options.
Outlook:
- Further research is needed to fully elucidate the long-term outcomes of various revascularization techniques in diabetic patients with complex coronary artery disease.
- Personalized treatment approaches considering individual patient factors and comorbidities are likely to become increasingly important.
Abstract:
CABG surgery has been considered the optimal revascularization strategy for patients with diabetes mellitus who have lexft main and/or multivessel coronary artery disease. The results of a new analysis of data from the SYNTAX trial challenge this conventional wisdom and highlight additional coronary revascularization options to physicians and patients.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease I: Introduction